Marathon Asset Management Ltd Sells 61,962 Shares of Envista Holdings Corporation $NVST

Marathon Asset Management Ltd reduced its holdings in shares of Envista Holdings Corporation (NYSE:NVST) by 8.9% during the fourth quarter, HoldingsChannel.com reports. The fund owned 637,484 shares of the company’s stock after selling 61,962 shares during the quarter. Marathon Asset Management Ltd’s holdings in Envista were worth $13,840,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Caitong International Asset Management Co. Ltd lifted its holdings in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock worth $31,000 after acquiring an additional 1,504 shares during the period. Allworth Financial LP lifted its holdings in Envista by 75.4% during the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock worth $39,000 after acquiring an additional 776 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after acquiring an additional 949 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares during the period. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in Envista during the third quarter worth $54,000.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on NVST. Morgan Stanley lifted their price target on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. UBS Group lifted their price target on Envista from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Tuesday, February 3rd. William Blair upgraded Envista from a “hold” rating to an “outperform” rating in a report on Friday, February 6th. JPMorgan Chase & Co. lifted their price target on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Leerink Partners set a $35.00 target price on Envista and gave the company an “outperform” rating in a research note on Friday, February 6th. Six research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, Envista presently has an average rating of “Hold” and an average price target of $28.83.

Envista Price Performance

Shares of NYSE NVST opened at $23.07 on Wednesday. The firm has a market capitalization of $3.75 billion, a P/E ratio of 56.26, a P/E/G ratio of 1.45 and a beta of 0.92. The company has a quick ratio of 2.06, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. The stock’s 50-day simple moving average is $25.74 and its two-hundred day simple moving average is $24.26. Envista Holdings Corporation has a twelve month low of $16.41 and a twelve month high of $30.42.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $705.50 million for the quarter, compared to analyst estimates of $680.04 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company’s quarterly revenue was up 14.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. As a group, equities analysts anticipate that Envista Holdings Corporation will post 1.43 EPS for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.